1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Prevalence and factors related to sleep apnoea in ankylosing spondylitis
(
- Contribution to journal › Article
-
Mark
Agreement of the modified Medical Research Council and New York Heart Association scales for assessing the impact of self-rated breathlessness in cardiopulmonary disease
(
- Contribution to journal › Article
-
Mark
The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies : Evidence from the Swedish CardioPulmonary bioImage Study
(
- Contribution to journal › Article
- 2021
-
Mark
A common model for the breathlessness experience across cardiorespiratory disease
(
- Contribution to journal › Article
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
(
- Contribution to journal › Letter
-
Mark
Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19 : population-based cohort study in Sweden (SCAPIS)
(
- Contribution to journal › Article
-
Mark
Systematic Coronary Risk Evaluation estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries : A population-based cohort analysis from the Swedish Cardiopulmonary Bioimage Study
(
- Contribution to journal › Article
-
Mark
The ratio FEV1/FVC and its association to respiratory symptoms—A Swedish general population study
(
- Contribution to journal › Article
-
Mark
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population
(
- Contribution to journal › Article
- 2020
-
Mark
Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease
(
- Contribution to journal › Article